Technology

iQIYI’s ‘Love On Theater’ Premieres ‘Fangs of Fortune,’ Setting Benchmark for C-Drama Virtual Production

Published

1 year ago

October 31, 2024

BEIJING, Oct. 31, 2024 /PRNewswire/ — iQIYI, China’s leading online entertainment platform, premiered Fangs of Fortune in late October, the latest release under ‘Love On Theater.’ Inspired by The Classic of the Mountains and Seas, an ancient Chinese mythological text, this fantasy period drama unfolds in a rich universe filled with Chinese cultural elements, brought to life through state-of-the-art technologies and virtual production.

Classical Chinese Culture and Romance

Presented by iQIYI and starring Neo HOU and Duling CHEN, Fangs of Fortune reinvents the Chinese fantasy narrative of “demons catching demons.” Featuring numerous mythological creatures from The Classic of the Mountains and Seas, the drama follows demon leader Zhu Yan, who, disguised as Yuanzhou ZHAO, infiltrates the “demon-hunting bureau.” Alongside the goddess Xiao WEN and other bureau members, they begin to unveil the truths behind the malicious acts of the demons and beasts they encounter.

Through laughter and tears, the demon-hunting squad experiences love and personal growth, healing and redeeming one other in a story enriched by the creative team’s bold interpretations and expressions of classical Chinese aesthetics.

Upon its release on October 26, Fangs of Fortune was received with great acclaim with its content popularity index surpassing 8,500, sparking widespread discussion on Chinese social media. As part of iQIYI’s ‘Love On Theater’ collection, Fangs of Fortune joins a slate of titles that bring Chinese romance and culture to a global audience, leading in both views and revenue across all regions and genres on iQIYI International.

Setting the Standard for Virtual Production in China

Fangs of Fortune is the third virtual production from iQIYI following the successes of My Journey to You and Fox Spirit Matchmaker: Red-Moon Pact, and continues pushing the boundaries of virtual production in Chinese television. The drama achieved remarkable success in precise HDR color management and virtual light matching, natural depth of field transitions, seamless blending of virtual and physical sets, realistic virtual sky and climate simulation system and 200+ FPS high-speed filming, leading the C-drama industry in terms of the amount of virtual production technology used, length of production cycle and scene count.

Unlike traditional filmmaking, virtual production technology greatly enhances efficiency and collaboration by creating virtual sets ahead of on-site filming. Since late 2020, iQIYI has led the way in applying and promoting virtual production technology, becoming one of China’s first streaming platforms to complete the entire filming and broadcasting process for virtually produced series. To advance its virtual production capabilities, iQIYI has also built a “Digital Asset Library” and its proprietary AI-powered IQStage virtual production system, amassing numerous accolades, virtual production patents, and software copyrights.

Building on the creative partnership behind My Journey to You, the team behind Fangs of Fortune pioneered innovative solutions, including an electric revolving stage that ensures synchronized rotation between physical and virtual sets to significantly reduce conversion times.

iQIYI’s virtual production capabilities have developed a full set of mature hardware selection standards and testing methods, all assembled in IQStage. This achieves a high degree of integration between software and hardware, setting the standard for virtual production quality and efficiency in China.

CONTACT: iQIYI Press, press@qiyi.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/iqiyis-love-on-theater-premieres-fangs-of-fortune-setting-benchmark-for-c-drama-virtual-production-302292883.html

SOURCE iQIYI

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

58 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

59 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

59 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated